A.R.T. Advisors’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRWD
BCM
SCM
MP
A.R.T. Advisors's IRWD Position: Q3 2019 in Review
A.R.T. Advisors sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2019, closing a stake of 123,571 shares — an estimated $1.35M sold.
A.R.T. Advisors first reported a position in IRWD in Q2 2013 and held it in 13 quarters. The position peaked at $3.98M in Q2 2016. 164 funds tracked by Wall St. Rank hold IRWD as of Q3 2019.
- A.R.T. Advisors reported no remaining Ironwood Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
- A.R.T. Advisors sold 123,571 Ironwood Pharmaceuticals shares in Q3 2019, an estimated $1.35M.
- A.R.T. Advisors first reported a position in Ironwood Pharmaceuticals in Q2 2013 and held it in 13 quarters.
- A.R.T. Advisors's Ironwood Pharmaceuticals position peaked at $3.98M in Q2 2016.
- 164 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2019.
Based on A.R.T. Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.